Neurolase

Revolutionising Neurosurgical safety and precision

Welcome to the Future

Neurolase is developing cutting edge technology in the pursuit of greater safety and precision in surgery.

Follow this website to keep informed of our journey into transforming the future of Neurosurgery.

30,000

People with brain cancer diagnosed every year globally, with a 47% projected increase in new brain tumour cases globally by 2045 compared to 2022.

27 Years

Average years of life lost due to brain tumours. Brain tumours have the highest number of years of life lost than any other cancer.

Surgery

Remains the cornerstone of treatment in brain cancer and is often the first step of the pathway in treating this condition.

It is paramount that this first surgery is as effective as possible.

Mission

Neurolase exists to improve brain tumour surgery and transform the lives of patients worldwide.

The first surgery should always be the most safe and precise possible.